Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Induction of immune tolerance to specific grass pollens is mediated by expansion and activation of regulatory T cell subsets—primarily those producing IL‑10 and/or TGF‑β—alongside shifts in antibody profiles favoring non-inflammatory subclasses. These changes collectively suppress allergic inflammation at both systemic and mucosal sites following exposure or therapy with relevant allergens. This multi-faceted modulation forms the mechanistic basis for current—and future—immunotherapeutic strategies against seasonal allergies due to grass pollens.
Expansion of regulatory T cells, cytokine modulation (increased IL-10/TGF-β), antibody class switching (IgE to IgG4/IgA)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System Modulation via Induction of Tolerance to Specific Grass Pollens (Grass Pollen IT).